There Is A Lot More To Say About the COVID-19 Vaccines

Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19)
A large Phase 2b/3 safety and efficacy study may begin as early as July 2020
Pfizer (PFE) and BioNTech (This content is for paid subscribers.

Please click here to subscribe or here to log in.